Venture Investment Associates — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Atmo develops AI-powered weather forecasting models that process real-time satellite, ground station, radar, and ocean buoy data to deliver forecasts at high resolution and speed.
Advanced ManufacturingAI & Machine LearningClimate TechSan Francisco, US
Alex Levy(Founder)inJohan Mathe(Founder)inJeremie Lequeux
Co-investorsAIX VenturesOffline VenturesPlug and Play VenturesScribble VenturesSignia Venture PartnersStartX+7 more
Corvus Robotics builds autonomous drones that perform warehouse inventory scanning and material handling automation for large enterprises across North America.
Advanced ManufacturingAI & Machine LearningIoTLogistics & Supply ChainRoboticsSan Francisco, US
Jackie Wu(CEO)inKabir Mohammed(Director)inCorvus Robotics. He(Founder)Jackie Wu Kabir Mohammed(Founder)Mohammed Kabir(Founder)Jonathan Sandau(Chief Software Architect)
Co-investorsY CombinatorCathexis VenturesCIBUS ENTERPRISE FUND II LPf7 VenturesGoAhead VenturesOne Way Ventures+9 more
ResistanceBio develops treatments to address drug resistance in cancer patients.
BiotechHealthtechSan Francisco, US
Nicholas Goldner(CEO)inChristopher Bulow(Founder)inKYLE LAPHAM(Executive Officer, Director)
BoardOMRI AMIRAV-DRORY(Director)in
Co-investorsAlumni VenturesFifty YearsY CombinatorAsymmetry VenturesBrightstone Venture CapitalCantos Ventures+11 more
Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.
HealthtechMedical DevicesSan Francisco, US
Shreya Mehta(CTO)inNick Damiano(CEO)inJohn Beck(Executive Officer)in
BoardBryan Kim(Director)Robert Weisskoff(Director)inBlayne Roeder(Director)
Co-investorsAstiaCloudStone CapitalDorm RoomF-Prime CapitalShangBay Capital LLCY Combinator+15 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





















